Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Mayinglong Pharmaceutical Group Co Ltd
600993Mayinglong Pharmaceutical Group Co., LTD. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. The company products pipeline primarily consists of functional cosmetics, functional care products, functional food, and Chinese herbal medicines, as well as hemorrhoid, gynecological, cough, and skin products; and medical instruments. It is also involved in the retail and wholesale of medical devices and drugs; provision of hospital medical services; and operation of hospitals. The company sells its products through online channels. Mayinglong Pharmaceutical Group Co., LTD. was founded in 1582 and is headquartered in Wuhan, China. Address: No. 100, Zhoujiawan, Wuhan, China, 430064
Analytics
Zielpreis von Wall Street
147.9 CNYKGV
23.0268Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 600993
Dividenden-Analyse 600993
Dividendenwachstum über 5 Jahre
52 %Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
28 %Verlauf der Dividende 600993
Bewertung der Aktie 600993
Finanzen 600993
Ergebnisse | 2019 | Dynamik |